Mondelēz International announced today a stronger set of expectations and principles on direct suppliers of palm oil to improve transparency and speed the transition to sustainable practices across the sector. In the Palm Oil Action Plan released today, the company… Read More ›
Uncategorized
Chernobyl nuclear disaster-affected areas spring to life, 33 years on
More than three decades after the devastating explosion at the Chernobyl nuclear power plant, parts of Belarus’ adjoining regions have sprung back to life and the biggest of them, Homiel, has become a leading destination for domestic and international investors.
HarvestPlus partnering with The Fork for Biofortification Test Case in Nigeria
HarvestPlus is partnering with The Fork to conduct initial research on the feasibility and desirability of applying blockchain technology to a biofortification value chain for vitamin A-biofortified orange maize in Nigeria.
Ecobank Transnational Incorporated debut $450 million Eurobond oversubscribed
Ecobank Transnational Incorporated, ETI (www.Ecobank.com), the Lomé-based parent company of the Ecobank Group, is pleased to announce that it has successfully raised $450 million in its debut Eurobond which was oversubscribed.
In rare cases, immune system fails despite HIV suppression
Antiretroviral therapy (ART) is usually very effective at suppressing HIV in the body, allowing a person’s immune system to recover by preventing the virus from destroying CD4+ T cells(link is external).
Kids living near major roads at higher risk of developmental delays, NIH study suggests
Young children who live close to a major roadway are twice as likely to score lower on tests of communications skills, compared to those who live farther away from a major roadway, according to an analysis by researchers at the National Institutes of Health and the University of California, Merced.
NIH to Test Experimental Drug to Curb Opioid Cravings
A clinical trial of an experimental drug designed to treat cravings associated with opioid use disorder (OUD) has begun in the National Institutes of Health Clinical Center.
